INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago

Most active filers · 30d

  1. 01Kurtz George0B / 217S · 10 late217 trades$54.77M
  2. 02SPSaba Capital Management, L.P.55B / 21S · 3 late76 trades$25.87M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05CFCheng Chi Fung0B / 42S42 trades$15.33M
  6. 06RARothblatt Martine A0B / 33S33 trades$5.50M
  7. 07RJRubinstein Julie0B / 32S32 trades$5.55M
  8. 08LBLeach Bryan0B / 30S30 trades$7.97M
  9. 09AOAtay Oguzhan0B / 30S30 trades$7.55M
  10. 10JDJenkins William D Jr0B / 30S30 trades$13.38M

Form 4 transactions

18,937 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
19
HK
Hanson KristopherGeneral Counsel
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$111K
3,908 sh
May 4, 2026May 6, 2026
Page 254 of 474
← PrevNext →

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
  4. SELL
traded May 4, 2026
+2d
SEC Form 4

Evidence

19
SV
Setia VishwasChief Financial Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$131K
4,803 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC Form 4

Evidence

19
HK
Hanson KristopherGeneral Counsel
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$248K
9,030 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC Form 4

Evidence

19
FP
Foff Erin PennockChief Medical Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$271K
9,645 sh
May 5, 2026May 6, 2026
traded May 5, 2026
+1dSEC Form 4

Evidence

19
FP
Foff Erin PennockChief Medical Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$463K
15.9K sh
May 6, 2026May 6, 2026
traded May 6, 2026
+0dSEC Form 4

Evidence

19
FP
Foff Erin PennockChief Medical Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$155K
5,460 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC Form 4

Evidence

18
MM
Matsuda MasaruSee Remarks
ARQTArcutis Biotherapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$172K
7,372 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC Form 4

Evidence

17
CD
Carr DouglasSVP Finance & Operations
IPSCCentury Therapeutics, Inc.
Open-market sale
SELL$618
264 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC Form 4

Evidence

17
DJ
Doyle Jonathan JDirector, Hd of Financial Services Group
PIPRPIPER SANDLER COMPANIES
Open-market sale
SELL$24K
300 sh
May 5, 2026May 6, 2026
traded May 5, 2026
+1dSEC Form 4

Evidence

16
IJ
Inrig JulaCHIEF MEDICAL OFFICER
TVTXTravere Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$101K
2,174 sh
May 5, 2026May 6, 2026
traded May 5, 2026
+1dSEC Form 4

Evidence

16
FP
Foff Erin PennockChief Medical Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$9,223
312 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC Form 4

Evidence

16
CR
Cline Christopher R.CHIEF FINANCIAL OFFICER
TVTXTravere Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$102K
2,181 sh
May 5, 2026May 6, 2026
traded May 5, 2026
+1dSEC Form 4

Evidence

16
SV
Setia VishwasChief Financial Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$60K
2,068 sh
May 6, 2026May 6, 2026
traded May 6, 2026
+0dSEC Form 4

Evidence

16
FP
Foff Erin PennockChief Medical Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$21K
700 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC Form 4

Evidence

16
SV
Setia VishwasChief Financial Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$238K
8,496 sh
May 6, 2026May 6, 2026
traded May 6, 2026
+0dSEC Form 4

Evidence

16
SV
Setia VishwasChief Financial Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$24K
787 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC Form 4

Evidence

16
FP
Foff Erin PennockChief Medical Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$229K
8,152 sh
May 6, 2026May 6, 2026
traded May 6, 2026
+0dSEC Form 4

Evidence

16
HK
Hanson KristopherGeneral Counsel
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$8,750
296 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC Form 4

Evidence

16
HK
Hanson KristopherGeneral Counsel
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$21K
683 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC Form 4

Evidence

16
SV
Setia VishwasChief Financial Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$9,607
325 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC Form 4

Evidence

14
WT
Watanabe ToddDirector, See Remarks
ARQTArcutis Biotherapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$75K
3,172 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC Form 4

Evidence

14
PR
Porter James RichardDirector, President and CEO
NUVLNuvalent, Inc.
Open-market sale · 10b5-1 plan
SELL$1.77M
17.4K sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC Form 4

Evidence

13
FP
Foff Erin PennockChief Medical Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$27K
931 sh
May 5, 2026May 6, 2026
traded May 5, 2026
+1dSEC Form 4

Evidence

13
CR
Cline Christopher R.CHIEF FINANCIAL OFFICER
TVTXTravere Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$14K
310 sh
May 6, 2026May 6, 2026
traded May 6, 2026
+0dSEC Form 4

Evidence

13
IJ
Inrig JulaCHIEF MEDICAL OFFICER
TVTXTravere Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$14K
311 sh
May 6, 2026May 6, 2026
traded May 6, 2026
+0dSEC Form 4

Evidence

13
SV
Setia VishwasChief Financial Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$28K
968 sh
May 5, 2026May 6, 2026
traded May 5, 2026
+1dSEC Form 4

Evidence

12
SA
Schlachet AmirDirector, CEO
GLBEGlobal-E Online Ltd.
Open-market sale · 10b5-1 plan
SELL$299K
9,450 sh
May 5, 2026May 6, 2026
traded May 5, 2026
+1dSEC Form 4

Evidence

11
HK
Holleran KevinDirector, President and CEO
HAYWHayward Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$764K
52.4K sh
May 5, 2026May 6, 2026
traded May 5, 2026
+1dSEC Form 4

Evidence

11
VL
Vairavan LathaSVP Chief Financial Officer
ARQTArcutis Biotherapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$32K
1,341 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC Form 4

Evidence

11
MM
Matsuda MasaruSee Remarks
ARQTArcutis Biotherapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$21K
884 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC Form 4

Evidence

9
OY
Ong Chin YinChief Org Capability Officer
GRABGrab Holdings Ltd
Open-market sale · 10b5-1 plan
SELL$136K
38.0K sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC Form 4

Evidence

8
LC
Liu CurtisDirector, Chief Technology Officer, 10% Owner
AMPLAmplitude, Inc.
Open-market sale · 10b5-1 plan
SELL$143K
17.6K sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC Form 4

Evidence

7
PR
Porter James RichardDirector, President and CEO
NUVLNuvalent, Inc.
Open-market sale · 10b5-1 plan
SELL$754K
7,429 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC Form 4

Evidence

5
FW
Fordenwalt Matthew W.SVP Lifecycle Services
ROKROCKWELL AUTOMATION, INC
Open-market sale · 10b5-1 plan
SELL$207K
460 sh
May 5, 2026May 6, 2026
traded May 5, 2026
+1dSEC Form 4

Evidence

4
PR
Porter James RichardDirector, President and CEO
NUVLNuvalent, Inc.
Open-market sale · 10b5-1 plan
SELL$140K
1,408 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC Form 4

Evidence

4
PR
Porter James RichardDirector, President and CEO
NUVLNuvalent, Inc.
Open-market sale · 10b5-1 plan
SELL$217K
2,111 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC Form 4

Evidence

4
PR
Porter James RichardDirector, President and CEO
NUVLNuvalent, Inc.
Open-market sale · 10b5-1 plan
SELL$167K
1,699 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC Form 4

Evidence

3
YS
Yi StevenDirector, See Remarks
MAXMediaAlpha, Inc.
Open-market sale · 10b5-1 plan
SELL$37K
4,000 sh
May 6, 2026May 6, 2026
traded May 6, 2026
+0dSEC Form 4

Evidence

3
YS
Yi StevenDirector, See Remarks
MAXMediaAlpha, Inc.
Open-market sale · 10b5-1 plan
SELL$36K
4,000 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC Form 4

Evidence

3
YS
Yi StevenDirector, See Remarks
MAXMediaAlpha, Inc.
Open-market sale · 10b5-1 plan
SELL$36K
4,000 sh
May 5, 2026May 6, 2026
traded May 5, 2026
+1dSEC Form 4

Evidence

FERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 16
7 insiders$7.38M
  • SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  • BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  • SELLIBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
  • SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K